These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Vacuoles, E1 enzyme, X-linked, autoinflammatory, and somatic syndrome in the intensive care unit: a case report. Belicard F; Belhomme N; Bouzy S; Saillard C; Nedelec F; Mear JB; Ardois S; Pastoret C; Reizine F; Camus C; Painvin B J Med Case Rep; 2023 Jul; 17(1):314. PubMed ID: 37480098 [TBL] [Abstract][Full Text] [Related]
9. Pulmonary manifestations of VEXAS syndrome with acute interstitial pneumonia and diffuse alveolar hemorrhage: a case report and literature review. Puseljic M; Schmid J; Igrec J; Hatzl S; Scholz L; Wölfler A; Fuchsjäger M; Talakic E ARP Rheumatol; 2024; 3(2):151-156. PubMed ID: 38956997 [TBL] [Abstract][Full Text] [Related]
10. A case of VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) with decreased oxidative stress levels after oral prednisone and tocilizumab treatment. Tozaki N; Tawada C; Niwa H; Mizutani Y; Shu E; Kawase A; Miwa Y; Ohnishi H; Sasai H; Miyako K; Hosokawa J; Kato A; Kobayashi K; Miyazaki T; Shirakami Y; Shimizu M; Iwata H Front Med (Lausanne); 2022; 9():1046820. PubMed ID: 36544501 [TBL] [Abstract][Full Text] [Related]
11. Skin Manifestations of VEXAS Syndrome and Associated Genotypes. Tan IJ; Ferrada MA; Ahmad S; Fike A; Quinn KA; Groarke EM; Beck DB; Allbritton J; Castelo-Soccio L; Young NS; Patel BA; Grayson PC; Cowen EW JAMA Dermatol; 2024 Jun; ():. PubMed ID: 38865133 [TBL] [Abstract][Full Text] [Related]
12. Clinical Manifestations in Vacuoles, E1 Enzyme, X-Linked, Autoinflammatory, Somatic (VEXAS) Syndrome: A Narrative Review. Padureanu V; Marinaș CM; Bobirca A; Padureanu R; Patrascu S; Dascalu AM; Bobirca F; Tribus L; Alexandru C; Serboiu C; Dumitrascu C; Musetescu A Cureus; 2024 Jan; 16(1):e53041. PubMed ID: 38410307 [TBL] [Abstract][Full Text] [Related]
13. VEXAS syndrome (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic): clinical review in a rapidly emerging field. Phan L; Hammond D; Wilson NR; Groarke EM; Patnaik MM; Pemmaraju N Leuk Lymphoma; 2024 May; ():1-13. PubMed ID: 38770970 [TBL] [Abstract][Full Text] [Related]
14. Ocular and orbital manifestations in VEXAS syndrome. Abumanhal M; Leibovitch I; Zisapel M; Eviatar T; Edel Y; Ben Cnaan R Eye (Lond); 2024 Jun; 38(9):1748-1754. PubMed ID: 38548942 [TBL] [Abstract][Full Text] [Related]
15. VEXAS syndrome: A review of cutaneous findings and treatments in an emerging autoinflammatory disease. Saad AJ; Patil MK; Cruz N; Lam CS; O'Brien C; Nambudiri VE Exp Dermatol; 2024 Mar; 33(3):e15050. PubMed ID: 38469984 [TBL] [Abstract][Full Text] [Related]